Literature DB >> 11193829

Integrative mitogenic role of protein kinase B/Akt in beta-cells.

K Trümper1, A Trümper, H Trusheim, R Arnold, B Göke, D Hörsch.   

Abstract

Protein kinase B/Akt (PKB/Akt) is activated by phosphatidylinositol 3-kinase (PI 3-K) and is a central mediator of cellular proliferation and protection against apoptosis. Insulin, insulin-like growth factor (IGF-1), and glucagon-like peptide-1 (GLP-1) act as glucose-dependent growth factors for pancreatic beta-cells. We assessed signaling pathways and stimulation patterns of PKB/Akt activation by these ligands in the beta-cell line INS-1. Insulin, IGF-1, and GLP-1 induced distinctive time dependent, dose dependent, and glucose dependent phosphorylation of PKB/Akt. Insulin and IGF-1 stimulated PI 3-K activity was mainly associated with insulin receptor substrate (IRS) isoforms IRS-1 and IRS-2 and less so with the IRS-isoform Grb-2 associated binder-1 (Gab-1). In contrast, GLP-1 induced PI 3-K activity mainly in Gab-1 and also in IRS-2 immunoprecipitates, although in an attenuated kinetic. Thus, activation pathways of PKB/Akt by insulin, IGF-1, and GLP-1 converge at the level of IRS-isoforms and PI 3-K inducing differential activation of PKB/Akt. These data indicate an essential role of PKB/Akt in regulation of beta-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193829     DOI: 10.1111/j.1749-6632.2000.tb06972.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

Review 1.  Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet.

Authors:  Alessandro Ustione; David W Piston; Paul E Harris
Journal:  Mol Endocrinol       Date:  2013-06-06

2.  Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment.

Authors:  Lloyd A Greene; Oren Levy; Cristina Malagelada
Journal:  Cell Mol Neurobiol       Date:  2011-03-10       Impact factor: 5.046

3.  The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells.

Authors:  J Trümper; D Ross; H Jahr; M D Brendel; R Göke; D Hörsch
Journal:  Diabetologia       Date:  2005-07-02       Impact factor: 10.122

4.  New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.

Authors:  G G Holz; G Holz
Journal:  Horm Metab Res       Date:  2004 Nov-Dec       Impact factor: 2.936

5.  Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.

Authors:  L Li; W El-Kholy; C J Rhodes; P L Brubaker
Journal:  Diabetologia       Date:  2005-05-19       Impact factor: 10.122

Review 6.  Diabetes outfoxed by GLP-1?

Authors:  George G Holz; Oleg G Chepurny
Journal:  Sci STKE       Date:  2005-01-25

7.  Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction.

Authors:  Subhas C Biswas; Jean Buteau; Lloyd A Greene
Journal:  Neurochem Res       Date:  2008-03-20       Impact factor: 3.996

8.  Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.

Authors:  Zhengyu Liu; Joel F Habener
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

9.  Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells.

Authors:  Q Wang; L Li; E Xu; V Wong; C Rhodes; P L Brubaker
Journal:  Diabetologia       Date:  2004-02-05       Impact factor: 10.122

10.  Glucagon-like peptide-1 prevents beta cell glucolipotoxicity.

Authors:  J Buteau; W El-Assaad; C J Rhodes; L Rosenberg; E Joly; M Prentki
Journal:  Diabetologia       Date:  2004-04-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.